Healthcare Pharmaceutical Biotech

Industry Giants Join EDGE Surgical Board of Directors

April 22, 2026 9:00 AM

EDGE Surgical, Inc., the pioneering force behind the world's only electronic depth gauge for orthopedic surgery, proudly announces the addition of Michael Frazzette and Matthew E. Monaghan to its Board of Directors. Both executives will play key roles in guiding the organization through its upcoming phase of commercial evolution and market expansion. Matt Monaghan brings over 35 years of global business leadership across public and private...

Read more

PrescribeDNA Introduces New Approach to Brain Health

April 22, 2026 8:00 AM

How one consultant's approach is reshaping the way women think about their cognition. "Your brain reflects the state of your body as a whole, yet it is rarely approached that way. Instead, it is often addressed in parts, without a clear, cohesive plan." PrescribeDNA was developed to change that. Dr. A (Alissa Huhn, PharmD, BCPP, CNGS, CPGx) is a board-certified psychiatric pharmacist and genetic specialist working with discerning women who...

Read more

Black Book Research: Croatia Healthcare IT Shifts From Digitization to Execution

April 22, 2026 7:30 AM

Black Book Research today released State of Digital Healthcare IT Croatia 2026, a new market intelligence report showing that Croatia has moved beyond early-stage healthcare digitization and into a higher-stakes phase where operational performance is now the central market issue. The report, part of the 30 country subset series of the 2026 Global Healthcare IT study by Black Book, finds that Croatia's national digital health backbone, anchored...

Read more

CBD Life Sciences Inc. (CBDL) Enters into Stock Purchase Agreement with FBC Holding Inc. to Acquire Mushroom Madness Inc. and Formrunner Apparel; Subsidiaries Now 100% Wholly Owned

April 22, 2026 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL) CBD Life Sciences Inc. is proud to announce the successful execution of a stock purchase agreement with FBC Holding Inc. Under the terms of this agreement, CBD Life Sciences Inc. has purchased 100% of the issued and outstanding stock of Mushroom Madness Inc. and Formrunner Apparel. This strategic acquisition ensures that both Mushroom Madness Inc. and Formrunner Apparel are now fully wholly owned subsidiaries of...

Read more

Margins Strengthened and Cash Flow Improved Despite a Temporary Dip in The Growth Trajectory. Full-Year Targets Remain on Track

April 22, 2026 2:20 AM

Senzime (STO:SEZI) (OTCQX:SNZZF) - Senzime AB's (publ) interim report for January - March 2026 is now available on the company's website www.senzime.com. Financial information January - March 2026 Net sales amounted to SEK 23,233 thousand (23,499), a decrease of 1% Currency-adjusted net sales increased by 11% Sales in US market amounted to SEK 14,805 thousand (15,551), a decrease of 5% Sales in other markets amounted to SEK 8,427 thousand...

Read more

Nanomerics Secures US Patent Extending MET Platform Protection to the 2040s

April 22, 2026 12:00 AM

Nanomerics Ltd., a clinical-stage speciality pharmaceutical company, today announced the grant of US Patent No. 12,606,641. This grant extends the protection of Nanomerics' Molecular Envelope Technology (MET) intellectual property rights to the 2040s. The grant follows the earlier grant of the corresponding European patent, with further applications pending in other jurisdictions. Nanomerics' MET is the first clinical-stage, non-irritant,...

Read more

Brain Memory Keeper Review 2026: Don't Buy Memory Support Supplement Before Reading This Report First!

April 21, 2026 9:30 PM

Disclaimers: This article contains affiliate links. If you click on these links and make a purchase, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented. This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any new supplement, particularly if you take...

Read more

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

April 21, 2026 7:01 PM

Moderna, Inc. (NASDAQ:MRNA) today announced that the first participants in the U.S. and UK have been dosed in a Phase 3 study of the Company's investigational mRNA-based H5 pandemic influenza vaccine candidate, mRNA-1018. In December 2025, the Coalition for Epidemic Preparedness Innovations (CEPI) and Moderna announced that CEPI will invest up to $54.3 million to help advance mRNA-1018 to licensure. "H5 influenza, or bird flu, remains a pandemic...

Read more

Onco-Innovations Announces Completion of Analytical Method Development for Monomer Intermediate 1 Supporting ONC010 Program

April 21, 2026 6:00 PM

Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") announces the successful completion of a significant milestone with Dalton Pharma Services ("Dalton"), focused on analytical method development for purity determination of Intermediate 1 (monomer) of its proprietary polymer platform supporting ONC010. The completed work includes development of a robust reverse-phase high-performance liquid...

Read more

Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details

April 21, 2026 4:45 PM

Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that it will host its First Quarter 2026 Earnings Conference Call on Wednesday, May 6, 2026, at 11:00 a.m. EDT. Interested parties may participate in the call by dialing: 877-407-6176 (US Toll-Free) +1 201-689-8451 (International) Live Audio Webcast:...

Read more

NHI Announces Sale of NHC Portfolio for $560 Million

April 21, 2026 4:22 PM

National Health Investors, Inc. (NYSE:NHI) today announced that it has executed a purchase and sale agreement to sell its portfolio of 32 skilled nursing facilities ("SNF") and three independent living facilities to National HealthCare Corporation ("NHC"), the current lessee, for $560.0 million. The Company expects to incur transaction costs in a range of $6.0 - $8.0 million and anticipates closing on July 1, 2026, subject to certain customary...

Read more

Dr. Kapadia Husain Zoher Calls for Greater Focus on Patient-Centered Dentistry

April 21, 2026 2:45 PM

Dr. Kapadia Husain Zoher, a Houston-based general dentist and founder of Vintage Smile, is speaking out about the importance of patient-centered dentistry and the need for greater awareness around oral health and patient comfort. Dr. Kapadia says that while dentistry has made major technological advances, the patient experience often receives less attention than it deserves. "Dentistry is about much more than teeth," Dr. Kapadia says. "It's...

Read more

Trump Pushes Cannabis Rescheduling as Hemp CMS Issues Play Out in Federal Court

April 21, 2026 2:30 PM

A federal lawsuit challenging the Centers for Medicare & Medicaid Services' decision to introduce hemp-derived cannabinoid access pathways into Medicare connected care models is rapidly becoming one of the most consequential cannabis policy cases in years. The litigation-supported by clinicians, constitutional scholars, and aligned with the regulatory position long advanced by MMJ International Holdings-centers on a simple but foundational...

Read more

Norton Leatherman Spine Surgeon Makes History With First in World Use of New Spine Surgery Robot

April 21, 2026 1:25 PM

Norton Leatherman Spine has reached a major milestone in the evolution of spine care. Jeffrey L. Gum, M.D., spine surgeon with Norton Leatherman Spine, has become the first in the world to perform spine surgery using a next-generation robotic-assisted platform designed to deliver greater precision and accuracy than any previous technology. Dr. Gum played a critical role in its development, contributing to both design and readiness for clinical...

Read more

MadeMed Review 2026: Is MadeMed Legit? GLP-1 Telehealth Pricing From $99, Compounded Semaglutide and Tirzepatide Programs, Men's Wellness, Peptide Therapy, and Platform Verification Guide

April 21, 2026 1:10 PM

MadeMed Complete 2026 Overview: Telehealth Platform Pricing, Compounded GLP-1 Programs, and What Prospective Patients Should Verify What "Claims Evaluated" Means in This Article This article examines publicly available information about MadeMed's telehealth platform - including the company's published pricing, program descriptions, regulatory disclosures, and terms of service. The goal is straightforward: present what the company states,...

Read more

3Aware Launches Evidence Vault to Help Health Systems Turn Clinical Data into Scalable Research and Revenue

April 21, 2026 1:00 PM

3Aware announced the launch of the Evidence Vault - a new, federated clinical research and commercialization infrastructure that enables health systems to participate as Commercial Data Partners while maintaining full control of their data, governance, and exports. The network of vaults, powered by 3Aware, is designed for health systems that want to expand investigator-led research, collaborate selectively, and support industry-sponsored studies...

Read more

Justera Announces CFO Appointments

April 21, 2026 1:00 PM

Justera Health Inc. (CSE:VTAL)(OTC:SCRSF) ("Justera" or the "Company") is pleased to announce the appointment of Bruce (Hwan) Lee as Chief Financial Officer of the Company, effective April 21, 2026. The Company notes that Mr. Lee has been appointed to fill the vacancy created by the resignation of former CFO Paul Haber on March 2, 2026. Mr. Lee's appointment is expected to further strengthen the Company's financial leadership, and reporting and...

Read more

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

April 21, 2026 12:50 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the U.S. introduction of the "18 Series" - a premium nutraceutical platform designed to meet growing consumer demand for clinically validated health solutions. 1. The 18 Series - Overview Cosmos Health Inc. is executing a disciplined, science-first strategy to build the what we believe to be most...

Read more

Enhance.MD Review 2026: New Pricing, Updated Pharmacy Partners, and the Regulatory Shifts Every GLP-1 Patient Should Understand

April 21, 2026 12:45 PM

Enhance.MD GLP-1 Complete 2026 Overview: The 4 Things to Verify Before You Enroll (Pricing, Pharmacies, Compliance, Commitment Terms) Updated April 21, 2026. This review is based on analysis of Enhance.MD's published website, terms of service, FAQ documentation, how-it-works page, and publicly available FDA regulatory guidance. No claims made here represent personal medical advice. If you have been researching GLP-1 telehealth programs, you...

Read more

RNK Health Sermorelin 2026: The Subscription Fine Print, Refund Policy, and FDA History That Most Reviews Leave Out

April 21, 2026 12:10 PM

Compounded Sermorelin Prescription Access Through Telehealth, the Three-Entity Clinical Structure Most Platform Comparisons Leave Out, No-Refund-After-Shipment Policy Details, FDA Approval History and Current Compounding Status, WADA Prohibition for Competitive Athletes, and 8 Clinician Questions That Should Drive Your Decision - Not Marketing Disclaimer: This article is for informational purposes only and does not constitute medical advice. It...

Read more